Experimental Huntington's drug shows promise in small safety study
NCT ID NCT07344519
First seen Jan 19, 2026 · Last updated May 23, 2026 · Updated 18 times
Summary
This early-stage study tested an experimental drug called ER2001 in 8 adults with early Huntington's disease. The main goal was to check if the drug is safe and how the body processes it. Participants received increasing doses of the drug through an IV over 6 weeks. This study is a first step to see if ER2001 might help control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUNTINGTON DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510080, China
Conditions
Explore the condition pages connected to this study.